Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

SELL
$98.98 - $115.74 $35,335 - $41,319
-357 Reduced 7.9%
4,164 $481,000
Q2 2023

Jul 26, 2023

BUY
$96.34 - $112.38 $101,349 - $118,223
1,052 Added 30.33%
4,521 $464,000
Q1 2023

Apr 27, 2023

BUY
$107.32 - $113.5 $166,453 - $176,038
1,551 Added 80.87%
3,469 $378,000
Q4 2022

Feb 02, 2023

BUY
$62.39 - $113.8 $119,664 - $218,268
1,918 New
1,918 $218,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.